Safety and efficacy of adjunctive perampanel in paediatric patients (aged 4 to <12 years) with partialonset seizures (POS) or primary generalised tonic-clonic seizures (PGTCS): Final results from the 311 core study
Perampanel is a once-daily oral anti-seizure drug for POS and

